Detalhe da pesquisa
1.
PI3Kδ inhibition by idelalisib in patients with relapsed indolent lymphoma.
N Engl J Med
; 370(11): 1008-18, 2014 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-24450858
2.
A phase 1 study of the PI3Kδ inhibitor idelalisib in patients with relapsed/refractory mantle cell lymphoma (MCL).
Blood
; 123(22): 3398-405, 2014 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-24615778
3.
Idelalisib, a selective inhibitor of phosphatidylinositol 3-kinase-δ, as therapy for previously treated indolent non-Hodgkin lymphoma.
Blood
; 123(22): 3406-13, 2014 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-24615776
4.
NF90 regulates inducible IL-2 gene expression in T cells.
J Exp Med
; 204(5): 971-7, 2007 May 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-17470640
5.
Combinations of idelalisib with rituximab and/or bendamustine in patients with recurrent indolent non-Hodgkin lymphoma.
Blood Adv
; 1(2): 122-131, 2016 Dec 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-29296805
6.
Overall survival analysis of a phase II randomized controlled trial of a Poxviral-based PSA-targeted immunotherapy in metastatic castration-resistant prostate cancer.
J Clin Oncol
; 28(7): 1099-105, 2010 Mar 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-20100959
7.
NF90 regulates cell cycle exit and terminal myogenic differentiation by direct binding to the 3'-untranslated region of MyoD and p21WAF1/CIP1 mRNAs.
J Biol Chem
; 280(19): 18981-9, 2005 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-15746098
8.
CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy.
Blood
; 106(9): 3068-73, 2005 Nov 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-16020508
9.
Cord blood CD4(+)CD25(+)-derived T regulatory cell lines express FoxP3 protein and manifest potent suppressor function.
Blood
; 105(2): 750-8, 2005 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15374887
10.
Ex vivo depletion of alloreactive cells based on CFSE dye dilution, activation antigen selection, and dendritic cell stimulation.
Blood
; 103(3): 1158-65, 2004 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-14525783
11.
In vitro-expanded human CD4(+)CD25(+) T-regulatory cells can markedly inhibit allogeneic dendritic cell-stimulated MLR cultures.
Blood
; 104(2): 453-61, 2004 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-15031211